NCT05997745

Brief Summary

Hospitals in South Kivu always have problems supplying artificial enteral nutritional products because of their high cost and low availability in our areas. While the Province has cereals, knowing their nutritional composition would enable the formulation of a nutritional product based on local protein-energy products. Hence the questions below: Can a local cereal-based protein-energy ration be used instead of a costly imported artificial nutritional solution to improve the nutritional status of patients operated on for PAG? What is the tolerance of this early enteral nutrition on the healing and functional recovery of patients compared with an artificial nutritional solution? To answer these questions, a randomized clinical trial has been designed with the following objectives:

  • To formulate an enteral diet using cereals available in our environment with a protein-calorie composition superimposable on the artificial enteral ration,
  • Evaluate the tolerance and advantages of early enteral nutrition with a locally manufactured protein-caloric ration vs. a commercially available artificial nutritional solution in patients undergoing surgery for PAG.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2023

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 7, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 18, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

August 20, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2023

Completed
Last Updated

August 18, 2023

Status Verified

July 1, 2023

Enrollment Period

2 months

First QC Date

August 7, 2023

Last Update Submit

August 11, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Tolerability of feeding

    We will screen complications after feeding

    10 days after surgery

Secondary Outcomes (1)

  • nutritional surveillance

    2 days after, 5 days after, 10 days after feeding

Study Arms (2)

study group

EXPERIMENTAL

an intervention arm consisting of patients who will receive the locally manufactured protein-energy ration after a laparotomy indicated for generalized acute peritonitis

Dietary Supplement: study group

control group

ACTIVE COMPARATOR

patients who will receive the commercially available protein-energy ration after a laparotomy indicated for generalized acute peritonitis

Dietary Supplement: study group

Interventions

study groupDIETARY_SUPPLEMENT

Patients will receive early enteral locally nutrition postoperatively following surgery for peritonitis

control groupstudy group

Eligibility Criteria

Age2 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • patient operated for peritonitis with intestinal suture during treatment
  • have a q-SOFA score of 1 to 2
  • surgeon's agreement to enteral feeding
  • at risk of malnutrition (BMC)

You may not qualify if:

  • q SOFA score \> 2
  • patients with tare (diabetes, HIV, renal failure)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Peritonitis

Condition Hierarchy (Ancestors)

Intraabdominal InfectionsInfectionsPeritoneal DiseasesDigestive System Diseases

Central Study Contacts

JEAN PAUL CIKWANINE, MASTER

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 7, 2023

First Posted

August 18, 2023

Study Start

August 20, 2023

Primary Completion

October 30, 2023

Study Completion

October 30, 2023

Last Updated

August 18, 2023

Record last verified: 2023-07